Pregnant W
Internal Medicine
2022-06-24

Pregnant Women With Polycystic Ovary Syndrome at Risk of Heart Complications During Delivery

Pregnant women with polycystic ovary syndrome (PCOS) appear to have an increased risk of adverse cardiovascular events and pregnancy outcomes at the time of birth, according to a study published in the Journal of the American Heart Association. Adverse outcomes included pre-eclampsia, peripartum cardiomyopathy, heart failure, abnormal heart rhythms, and venous thromboembolism. “Oftentimes, women with PCOS are understandably concerned about the immediate effects, like an irregular menstrual cycle, excess body hair, weight gain, and acne,” said Erin Michos, MD, Johns Hopkins University Sch...

Study comp
Internal Medicine
2022-06-22

Study compares risk of long COVID associated with delta versus omicron variants of SARS-CoV-2

Findings from a study published in The Lancet suggest reduced odds of long COVID with the severe acu...

Immune res
Internal Medicine
2022-06-20

Immune response to vaccination against SARS-CoV-2 in hematopoietic stem cell transplantation an...

A meta-analysis published in the Journal of Hematology and Oncology evaluated the immune responses t...

Videos from category: Cardiology

Novelties
9:16

Novelties in the diagnosis and management of primary aldosteronism

ESH 2022
Detecting
7:38

Detecting elevated lipoprotein(a) and addressing the ASCVD risks

EAS 2022
Who needs
6:58

Who needs injectable therapies for cholesterol lowering or statins and ezetimibe are enough for CVD prevention?

EAS 2022
The differ
2:47

The difference between the genetic and pharmacological inhibition of PCSK9

EAS 2022

Videos from category: Dermatology

Long-term
8:46

Long-term efficacy and safety of ixekizumab

Treatment
8:50

Treatment options of chronic urticaria

EADV Symposium 2022
Psoriasis
6:51

Psoriasis is a systemic disease

EADV 2020
New non-al
6:36

New non-allergenic, anti-inflammatory fragrance could be game changer for dry skin sufferers

EADV 2020

Videos from category: Diabetology

Liraglutid
13:26

Liraglutide for Weight Management in the Real World

The role o
10:22

The role of GLP-1 receptor agonists in weight reduction and cardiovascular risk reduction

Clinical I
8:59

Clinical Impact of Liraglutide as a Treatment of Obesity

Associatio
2:59

Associations of hypoglycaemia and glycaemic variability with cardiac arrhythmias using a long-term monitoring approach in insulin-treated patients with type 2 diabetes

EASD 2021

Videos from category: Gastroenterology

Duodenal m
11:01

Duodenal mucosal resurfacing shown to discontinue insulin treatment in majority of type 2 diabetes patients and aid weight loss

UEG 2020
Allergy-re
7:48

Allergy-related diseases and IBS

UEG 2020
A Next-Gen
3:06

A Next-Generation, Dual-Action Anti-Integrin Therapy for IBD

ECCO 2020
How to seq
2:20

How to sequence advanced therapies in IBD

ECCO 2020

Videos from category: Hematology

Novelties
8:35

Novelties in the treatment of myelofibrosis and polycythemia vera 2021

ASH 2021
Novelties
12:44

Novelties in the treatment of multiple myeloma 2021

ASH 2021
Risks for
5:01

Risks for Hospitalization and Death Among Patients with Blood Disorders from the ASH RC COVID-19 Registry for Hematology

ASH 2021
Antibody R
7:02

Antibody Response to Vaccination with Myeloid and Lymphoid Neoplasms

ASH 2021

Videos from category: Internal Medicine

Important
8:39

Important messages from EULAR2021: Impact of air pollution on RA flares, effect of COVID-19 on RA care, osteoporosis care of men

EULAR 2021
What is th
14:04

What is the role of transdermal fentanyl patches in management of cancer pain?

PAINWeek 2020
Which are
4:59

Which are the most promising new medications in phase 3 clinical trials for the treatment of painful large joint arthritis?

PAINWeek 2020
Optimising
8:42

Optimising the monitoring and treatment of SSc-ILD

EULAR 2020

Videos from category: Oncology

Results fr
5:010

Results from the phase 3 PARADIGM trial

ASCO 2022
Pembrolizu
6:32

Pembrolizumab in CRC: What did we learn from the KEYNOTE-177 and the KEYNOTE-651 trials?

ASCO 2022
Early brea
6:31

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

ESMO Breast Cancer 2022
Novelties
6:04

Novelties at the International Summit of Lung Cancer in Rome

International Summit of Lung C

Videos from category: Psychiatry

Novel Phar
8:13

Novel Pharmacotherapeutic Strategies for Regaining Control over Alcohol Intake in Alcohol Use Disorder

EPA 2021
Consequenc
7:54

Consequences of COVID-19 Outbreak on Mental Health

EPA 2021
Obstetric
6:010

Obstetric Complications: The Forgotten Risk Factor for Schizophrenia

EPA 2021
Meeting th
15:41

Meeting the challenges of schizophrenia care during the COVID-19 pandemic

EPA 2021

Videos from category: Respiratory

The digita
11:38

The digital age: The future of respiratory medicine

ERS 2021
Pulmonary
7:05

Pulmonary hypertension and interstitial pulmonary fibrosis

ERS 2021
ERS/EAACI
8:50

ERS/EAACI statement on adherence to international adult asthma guidelines

ERS 2021

Videos from category: Urology

Balancing
13:20

Balancing efficacy and quality of life measurements among metastatic renal cell carcinoma studies

EAU 2021

Suggested videos

By Author
By Topic
By Congress
4:21
Highlights of the 17th St. Gallen International Breast Cancer Conference
St. Gallen BCC 2021
11:06
IMpassion031: Results from a phase III study of neoadjuvant atezolizumab + chemotherapy in early triple-negative breast cancer
ESMO 2020
7:07
KEYNOTE-024 5-year OS update: first-line pembrolizumab vs platinum-based chemotherapy in patients with metastatic NSCLC and PD-L1 tumor proportion score ≥50%
ESMO 2020
13:09
A Polypill for Primary Prevention of Cardiovascular Disease in Intermediate Risk People: Results of the International Polycap Study (TIPS)-3
AHA 2020
6:09
PARADISE-MI: Prospective Arni Versus Ace Inhibitor Trial To Determine Superiority In Reducing Heart Failure Events After Myocardial Infarction
ACC 2021
15:58
2020 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease
ESC 2020
11:15
EXPLORER-HCM: Efficacy and Safety of Mavacamten in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
ESC 2020
9:28
Trifluridine/tipiracil or regorafenib in refractory metastatic colorectal cancer patients: An AGEO prospective “real life” study
ASCO 2020
16:51
Detailed summary of the Consensus Session of the SG-BCC 2021
St. Gallen BCC 2021
8:49
First safety and efficacy results of PRADO: A phase II study of personalized response-driven surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in resectable stage III melanoma
ASCO 2020
7:46
Inspiration-S Double Blind Randomized Controlled Trial: Atorvastatin Versus Placebo In Critically-ill Patients With Covid-19
ACC 2021
7:44
Summary of clinical and scientific topics discussed at EASD 2020 congress
EASD 2020
6:41
The Vital Rhythm Trial: Omega-3 Fatty Acid and Vitamin D Supplementation in the Primary Prevention of Atrial Fibrillation
AHA 2020
11:38
ESH-ISH 2021 Late-Breakers Session
ESH-ISH 2021
14:31
ESC Gold Medal 2020 Winner: Kari Stefansson
ESC 2020
11:28
Effects of empagliflozin on physical activity and compensatory appetite responses in people with type 2 diabetes: the SEESAW trial
EASD 2020
15:49
Hypertension Guidelines: Do They Vary Across the World as Much as My Blood Pressure Has Today?
ACC 2021
14:49
The role of cancer immunotherapy in the treatment of patients with early triple negative breast cancer
St. Gallen BCC 2021
9:01
A Three-arm N-of-1 Trial With Statin, Placebo and Tablet Free Periods, to Verify Side Effects and Identify Their Cause: The SAMSON Trial
AHA 2020
4:08
New Research Reveals that Risky Sexual Behaviour and STIs are on the Rise Despite COVID-19 Pandemic
EADV 2020
4:48
PRADA Trial: Prevention Of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: Long-term Follow-up Of A 2 X 2 Factorial, Randomized, Placebo-controlled, Double-blind Clinical Trial Of Candesartan And Metoprolol
ACC 2021
4:59
Which are the most promising new medications in phase 3 clinical trials for the treatment of painful large joint arthritis?
PAINWeek 2020
8:42
Optimising the monitoring and treatment of SSc-ILD
EULAR 2020
9:11
Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study
EHA 2020
17:43
Recognizing and Addressing Risk in Patients with HR-positive, HER2-negative Early Breast Cancer
St. Gallen BCC 2021
8:58
Accumulated CV data from SGLT2i outcomes trials
EASD 2020
6:13
Breast cancer highlights from ESMO2020
ESMO 2020
9:42
De-escalation of early breast cancer therapy: Umberto Veronesi’s legacy
St. Gallen BCC 2021
5:09
ADAPTABLE Study: Aspirin Dosing: A Patient-centric Trial Assessing Benefits And Long-term Effectiveness Trial
ACC 2021
Search by Scientific Content
Search by Congress
Search:
Date
Filters:
Novelties
9:16
Title Description

Novelties in the diagnosis and management of primary aldosteronism

Presenter: Constantine Stratakis
Cardiology : Hypertension
ESH 2022
Detecting
7:38
Title Description

Detecting elevated lipoprotein(a) and addressing the ASCVD risks

Presenter: Florian Kronenberg
Cardiology : Atherosclerosis
EAS 2022
Results fr
5:010
Title Description

Results from the phase 3 PARADIGM trial

Presenter: Yoshino Takayuki
Oncology
ASCO 2022
Pembrolizu
6:32
Title Description

Pembrolizumab in CRC: What did we learn from the KEYNOTE-177 and the KEYNOTE-651 trials?

Presenter: Richard D. Kim
Oncology
ASCO 2022
Who needs
6:58
Title Description

Who needs injectable therapies for cholesterol lowering or statins and ezetimibe are enough for CVD prevention?

Presenter: Carl Orringer
Cardiology : Atherosclerosis
EAS 2022
Early brea
6:31
Title Description

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Presenter: Sibylle Loibl
Oncology : Breast Cancer
ESMO Breast Cancer 2022
The differ
2:47
Title Description

The difference between the genetic and pharmacological inhibition of PCSK9

Presenter: Giuseppe Danilo Norata
Cardiology : Atherosclerosis
EAS 2022
ESC/EAS jo
10:13
Title Description

ESC/EAS joint session: What is new in secondary CV prevention?

Presenter: Ulrich Laufs
Cardiology : Atherosclerosis
EAS 2022
Treatment
8:50
Title Description

Treatment options of chronic urticaria

Presenter: Margarida Gonçalo
Dermatology
EADV Symposium 2022
ESC/EAS jo
6:38
Title Description

ESC/EAS joint session: Advances in CV risk estimation with focus on dyslipidemia

Presenter: Ian Graham
Cardiology : Atherosclerosis
EAS 2022
Novelties
6:04
Title Description

Novelties at the International Summit of Lung Cancer in Rome

Presenter: Federico Cappuzzo
Oncology : Lung Cancer
International Summit of Lung Cancer
Atrial fib
19:010
Title Description

Atrial fibrillation guidelines into clinical practice

Presenter: Daniel Scherr
Cardiology
EHRA 2022
Recent dev
7:02
Title Description

Recent developments of the conduction system pacing

Presenter: Hung-Fat Tse
Cardiology
EHRA 2022
Conduction
7:07
Title Description

Conduction system pacing: ready for prime time?

Presenter: Mauro Biffi
Cardiology
EHRA 2022
What do ne
7:17
Title Description

What do new guidelines tell us about conduction system pacing?

Presenter: Michael Glikson
Cardiology
EHRA 2022
Antithromb
5:33
Title Description

Antithrombotic Approaches to Reduce the Risk of Secondary Event in CAD and PAD

Presenter: Marc P. Bonaca
Cardiology
ACC 2022

Lectures

Carfilzomi
6:49

Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Primary Analysis Results from the Randomized, Open-Label, Phase 3 Study Candor

Presenter: Saad Z. Usmani
Hematology
Inhibition
6:22

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease: Results from the Phase 3 Cardinal Study

Presenter: Alexander Röth
Hematology
The QUAZAR
8:20

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia in First Remission

Presenter: Andrew H. Wei
Hematology
Validation
7:11

Validation of BCL11A As Therapeutic Target in Sickle Cell Disease: Results from the Adult Cohort of a Pilot/Feasibility Gene Therapy Trial Inducing Sustained Expression of Fetal Hemoglobin Using Post-Transcriptional Gene Silencing

Presenter: David A. Williams
Hematology
A Randomiz
4:40

A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in High and Intermediate Risk First Relapse of B-ALL in Children and Adolescents/Young Adults Demonstrates Superior Efficacy and Tolerability of Blinatumomab

Presenter: Patrick A. Brown
Hematology
CLARIFY -
7:07

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommanded therapies. Final 5-year results from the CLARIFY study

Presenter: Emmanuel Sorbets
Cardiology
SWEDEHEART
5:26

SWEDEHEART: Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

Presenter: Erik Bjoerklund
Cardiology
ICD use in
4:31

ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study

Presenter: Benedikt Schrange
Cardiology
PURE: Impa
10:51

PURE: Impact of modifiable risk factors on cardiovascular disease and mortality

Presenter: Salim Yusuf
Cardiology
RAPIDTnT:
5:37

RAPIDTnT: A randomised trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T

Presenter: Derek Chew
Cardiology
ENTRUST-AF
7:45

ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients

Presenter: Andreas Goette
Cardiology
POPular Ge
6:51

POPular Genetics - Genotype-guided oral P2Y12-inhibition in patients with St-segment elevation myocardial infarction undergoing primary PCI : a randomized, open-label, multicenter trial

Presenter: Jurrien M. Ten Berg
Cardiology
Combined e
5:03

Combined effect of lower LDL-C and lower SBP on the lifetime risk od cardiovascular disease

Presenter: Brian A. Ference
Cardiology
AFIRE - Ri
4:47

AFIRE - Rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease

Presenter: Satoshi Yasuda
Cardiology
GALACTIC -
7:23

GALACTIC - Goal-directed AfterLoad Reduction in Acute Congestive Cardiac Decompensation: a randomized controlled trial

Presenter: Christian Eugen Mueller
Cardiology
Salt subst
5:16

Salt substitution and community-wide reduction in blood pressure and hypertension incidence

Presenter: J. Jaime Miranda
Cardiology
Long-term
8:46
Title Description

Long-term efficacy and safety of ixekizumab

Presenter: Andrew Blauvelt
Dermatology
Paradigm s
12:05
Title Description

Paradigm shift in the early NSCLC? The role of ICIs in the adjuvant treatment

Presenter: Federico Cappuzzo
Oncology
How will t
9:43
Title Description

How will the current therapeutic options change the treatment of RCC in the daily practice?

Presenter: Camillo Porta
Oncology
The role o
5:58
Title Description

The role of immune checkpoint inhibitors and VEGF TKIs in the adjuvant treatment of renal cell carcinoma

Presenter: David F. McDermott
Oncology
Treatment
11:50
Title Description

Treatment intensification in the treatment of prostate cancer

Presenter: Oliver Sartor
Oncology
Pembrolizu
16:35
Title Description

Pembrolizumab as post nephrectomy adjuvant therapy for patients with renal cell carcinoma

Presenter: Stefan N. Symeonides
Oncology
State of t
6:13
Title Description

State of the art treatment of bladder cancer

Presenter: Matthew R. Zibelman
Oncology
First-line
7:41
Title Description

First-line pembrolizumab plus chemotherapy versus chemotherapy in advanced esophageal cancer

Presenter: Ken Kato
Oncology
Treatment
3:27
Title Description

Treatment of iron deficiency in acute and chronic heart failure

Presenter: Piotr Ponikowski
Cardiology
Alcohol se
6:32
Title Description

Alcohol septal ablation in hypertrophic cardiomyopathy: past and future

Presenter: Hubert Seggewiss
Cardiology
The use of
3:35
Title Description

The use of SGLT2 inhibitors in the prevention and treatment of heart failure

Presenter: Petar M. Seferovic
Cardiology
Direct myo
5:15
Title Description

Direct myosin inhibitors in hypertrophic cardiomyopathy: a new era?

Presenter: Iacopo Olivotto
Cardiology
Diagnostic
10:55
Title Description

Diagnostic delay in pulmonary arterial hypertension

Presenter: Barbro Kjellström and Bodil Ivarsson
Clinical I
6:21
Title Description

Clinical Impact of Liraglutide as a Treatment of Obesity

Presenter: Babak Dehestani
Internal Medicine
Associatio
20:17
Title Description

Association of GLP 1 Analogs and Agonists Administered for Obesity with Weight Loss and Adverse Events

Presenter: Michael Camilleri
Internal Medicine
Liraglutid
13:26
Title Description

Liraglutide for Weight Management in the Real World

Presenter: Roman Vangoitsenhoven
Cardiology , Diabetology